Novel Antimicrobials and AMR Diagnostics 2019


Overview of preliminary programme structure

Day 1 (14 March, Thursday)
15:30 Preconference Meeting: BEAM Alliance Members
16:30 Registration
17:00 Official Opening & Welcome
17:30- 18:30

Policy Forum (Plenary Session)

•WHO and UNCTAD will provide a discussion platform about the challenges of public and private investments in the AMR field


• Opportunity to get in touch with AMR relevant investors in 1-to-1 Meetings

19:00 Evening Reception


Day 2 (15 March, Thursday)
8:00 Registration

Plenary Session & Keynotes

  • Relevant investors, initiatives and industry stakeholders provide an update & progress report with regard to AMR innovations for human and animal health
10:30 Coffee Break with Exhibition & Poster Session
11:00Parallel Tracks 1-3
Track 1
Clinical Development & Regulation
Clinical design & methods, clinical trial networks & recruitment, candidate selection, etc.
Track 2
Market Access
Pull incentives - what is needed and already implemented, broken economic models, etc.
Track 3
Its role, problems and limits in AMR R&D; diagnostics, etc.
12:30Lunch Break with Exhibition & Poster Session & 1-to-1 Investors Meetings
14:00Parallel Tracks 4-6
Track 4
Innovation in Therapeutics for Humans
Track 5
Innovation in Diagnostics for Humans
Track 6
Innovations in Animal Health (Therapeutics & Diagnostics)
15:30Coffee Break with Exhibition & Poster Session

Financing Session

  • Start-Up Pitch
  • Investor's Talk
  • 1-to-1 Investors Meeting
17:00Start-up Ceremony & Networking Reception